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To synthesise results of population surveys assessing knowledge and attitudes about pre-
vention and treatment of dementia.
Methods
MEDLINE, EMBASE, PsycINFO, and grey literature were searched for English language
entries published between 2012 and May 2017. Survey questions were grouped using an
inductive approach and responses were pooled.
Results
Thirty-four eligible studies and four grey literature items were identified. Surveys were con-
ducted in Europe, the US, Eastern Asia, Israel, and Australia. Nearly half of respondents
agreed that dementia is a normal and non-preventable part of ageing, but belief in the poten-
tial for prevention may be improving over time. The role of cardiovascular risk factors was
poorly understood overall. Less than half of respondents reported belief in the availability of
a cure for dementia. The value of seeking treatment was highly endorsed.
Conclusions
Results suggest that knowledge about the potential for dementia prevention and treatment
remains poor but may be improving over time. Knowledge among those living in low- and
middle-income countries are largely unknown, presenting challenges for the development of
National action plans consistent with World Health Organization directives.
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Introduction
Approximately 47 million people worldwide are living with dementia (otherwise known as
major neurocognitive disorder) and a new diagnosis is given every three seconds [1]. While
research has not yet discovered a cure, there is accumulating evidence about the potential to
prevent approximately one third of cases of dementia with management of risk factors such as
poor educational attainment, hypertension, and depression [2]. In addition, both pharmaco-
logical and non-pharmacological treatments exist that can delay functional and cognitive
decline [3,4], help to manage behaviour change [5,6], and improve wellbeing [7,8].
The recently adopted World Health Organization (WHO) Global Action Plan on Dementia
urges all countries to implement campaigns to raise awareness about dementia [9]. The plan
includes a global target that all member countries will have “at least one functioning public
awareness campaign on dementia to foster a dementia-inclusive society by 2025” [9]. This
focus reflects that population risk reduction and appropriate treatment for dementia rely on a
contemporary understanding of these factors among the general public. Optimism about
potential treatments can encourage early diagnosis, which allows for future planning and facil-
itates access to peer support, known to protect against psychological distress [10]. Understand-
ing the modifiable risk factors for dementia may encourage preventative health behaviours in
early and mid-life, ultimately reducing late-life incidence (and associated costs). However,
misconceptions about dementia have been present for many years, including that dementia is
a normal part of ageing and that there is no value in pursuing treatment [11]. These miscon-
ceptions have been noted to contribute to diagnostic delay as health professionals, people with
symptoms and their families believe nothing can be done [12]. They also alleviate pressure on
policy makers to devote funding to prevention and treatment services [13].
A systematic review of papers published to mid-2014 conducted by Cahill and colleagues
[11] identified 40 studies of dementia literacy and reported only fair to moderate knowledge of
dementia and a sparsity of evidence available in low- and middle-income countries. Since that
time, major milestones in research and policy have occurred including the publication of hall-
mark reviews establishing the potential of dementia prevention [14], the proliferation of
‘dementia friendly community’ initiatives [15], and the establishment of dementia as a global
health priority by WHO [9]. Public awareness campaigns have also become more prolific and
have been delivered across a wider variety of platforms including social media [16]. However,
many of these campaigns still focus on either the ‘catastrophic’ consequences of dementia or
deliver overly simplistic or confusing messaging [17]. Whether such campaigns result in
improved literacy about dementia prevention and treatment can inform future campaigns.
This is particularly pertinent to the many low- and middle-income countries in the process of
developing their first dementia action plans in response to the WHO directives. Previous
reviews have not provided clear guidance about the key areas on which these campaigns
should focus.
The aim of this review was to build on the work conducted by Cahill and colleagues by
searching for more recent studies examining the population’s knowledge and understanding
of dementia, and using this data to identify key target areas for public health focus We deliber-
ately included only studies published in the past five years to represent contemporary thinking
and explored whether there have been improvements in literacy over time. We endeavoured to
understand whether the general public understand dementia as a preventable and treatable
condition consistent with currently available evidence.
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Methods
The review protocol was registered on the PROSPERO database (CRD42017062286), and we
report according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines. A checklist of PRISMA items is presented in S1 Table.
Data sources and searches
We searched MEDLINE, EMBASE and PsycINFO for English language studies published
between 2012 and May 2017. We searched this timeframe only to report how closely contem-
porary views resemble recent available evidence about dementia prevention and treatment.
The search strategy is available in S2 Table. Reference lists of all included studies were hand-
searched for additional records. We also searched grey literature via a general internet search,
Open Grey Europe, the Grey Literature Report, Web of Science, and report publications from
Alzheimer’s Disease International, national peak dementia organisations and the World
Health Organisation.
Eligibility criteria
Studies were included if they:
(a) Reported quantitative results of a survey (conducted via any method) of the general
population;
(b) Included at least one question regarding views, knowledge, beliefs, or attitudes about pre-
vention and/or treatment of dementia. Outcomes included knowledge about the exis-
tence of prevention or treatments strategies for dementia, as well as perceived efficacy of
specific strategies, and;
(c) Were published from 2012 onwards.
Conference abstracts were included only if they provided quantitative data that could be
used in the analysis.
Studies were excluded if they:
(a) Surveyed a specific population, such as people with dementia, carers of people with
dementia, particular health professionals, or University students;
(b) Assessed attitudes to ageing in general or non-dementia conditions;
(c) Assessed fear of dementia, willingness to be screened for dementia (e.g. genetic testing),
or stigma about dementia, unless the question directly related to prevention or treatment
of dementia (e.g. “I would be screened for dementia because there are there are treat-
ments to slow progression of the disease”);
(d) Reported results qualitatively only. Where a study reported mixed-methods results, only
quantitative data was extracted and included;
(e) Reported results of a subset of participants from another, larger included study, or;
(f) Were published in a language other than English.
We requested raw data from authors where only synthesised results of a validated scale
were reported (e.g. the Alzheimer’s Disease Knowledge Scale [18]).
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Study selection and data extraction
Study titles, abstracts, and full-texts were independently accessed and reviewed for eligibility
by two authors. A data extraction form was developed and piloted with five studies before
being finalised and used with the remaining studies. Two authors extracted the data, and this
was then checked by a third author. Extracted data included authors, year of survey and publi-
cation, study aims, study design, sampling method, data collection method, participant details,
and results.
Quality assessment
Risk of bias was assessed at the study level. Two authors independently assessed the methodo-
logical quality of included studies using the ‘Qualitative descriptive studies’ section of the
Mixed Methods Appraisal Tool (MMAT) [19]. The tool asks four yes/no/unclear questions:
(1) is the sampling strategy relevant to address the quantitative research question? This crite-
rion was met where the sampling method was clearly stated and appropriate to recruit a repre-
sentative sample; (2) Is the sample representative of the population under study? This criterion
was met where the inclusion and exclusion criteria were clearly explained, and participant
characteristics were described; (3) Are measurements appropriate? Measures were considered
appropriate where the question asked is clearly defined and asked similarly to all participants,
and; (4) Is there an acceptable response rate? This criterion was satisfied with a response rate
of 60 per cent or above. Quality assessment data were not used in data synthesis (see below)
but were considered during interpretation of results to identify potential bias.
Data synthesis
Two authors synthesised data by grouping similar responses into categories using an inductive
approach modelled from McCullough et al [20]. Fixed responses (and the proportion of
respondents endorsing them) were extracted and first grouped into six overarching categories
that emerged from the data: general knowledge about dementia prevention, risk factors, pro-
tective factors, general knowledge about dementia treatment, pharmacological treatment, and
non-pharmacological treatment. Data within these six categories were then organised into
more specific groups where similar concepts were referenced. Groupings were checked by a
third author. The specific items and categories used for prevention and treatment studies are
available in S3 and S4 Tables respectively. Where studies reported a percentage of the sample
agreeing with a statement, these were pooled and a median, interquartile range (IQR) and
range were calculated. Answers were reverse coded where necessary. We plotted trends over
time (by survey year) and compared continent responses (Europe, North America, Asia, Aus-
tralia) to the four most commonly reported statements: ‘Dementia is a normal part of ageing’;
‘Dementia is not preventable’, ‘There is a cure for dementia’, and ‘Effective treatments exist for
dementia’.
Results
The search strategy identified 1364 unique records, and one additional citation was identified
through hand-searching and grey literature searches. Following title and abstract screening,
1365 records were excluded due to non-relevance or not meeting inclusion criteria. One-hun-
dred-and-one articles were accessed in full-text (S1 Fig). Of these, 33 met all inclusion criteria
and were included in the review. Reasons for exclusion included that records did not discuss
knowledge of treatment or prevention (n = 30), dementia (n = 3), or knowledge or attitudes
(n = 6), were conference abstracts and provided insufficient detail (n = 7), included qualitative
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data only (n = 3), included data reported by a specific group (e.g. carers of people with demen-
tia, medical professionals; n = 12), used the same data as another included record (n = 5), or
did not provide raw scores (n = 2). The grey literature search revealed a conference abstract by
Mi-Ra et al [21], a conference presentation by Dos Santos et al [22], and a research report by
Dementia Australia [23]. Thirty-one studies reported data suitable for pooling. In total, the
included studies surveyed 36,519 participants.
Characteristics of included articles
Studies were published between 2012 and 2017 but reported on surveys conducted between 2008
and 2017 (Table 1). Study samples ranged from 50 to 3006 participants. Six of the eligible studies
asked about the feasibility of treatments for dementia, seven asked about dementia prevention,
and the remaining 19 included questions about both. Most surveys were conducted in Europe
(n = 12), (UK, France, Germany, Poland, Spain, Portugal, Northern Ireland, Denmark, Italy).
Eleven were conducted in the US, seven in Asia (China, South Korea, Singapore, Israel), and two
in Australia. Africa, South and Central America, Canada, and Southern and Western Asia were
not represented in any study. Six studies gathered views of specific ethnic groups within their
country, including Black and Caribbean British communities [24], South Asian people living in
the UK [25], Polish, Turkish, Danish, Pakistani people living in Denmark [26], or Chinese Ameri-
cans [27–29]. Participants in most studies were randomly sampled via digit dialling or online
access panels (n = 14) or convenience sampled via health and community services (n = 10).
Results of quality assessment
Results of the quality assessment are presented in S5 Table. Most studies were well-designed to
gauge the views of the broad population of interest, and largely reported sample characteristics
and results appropriately. All studies used standardised questions to gauge knowledge and atti-
tudes and asked these consistently. However, only 17 reported their response rate and nine of
these were below the ‘accepted’ threshold of 60 per cent.
Knowledge about dementia prevention
Twenty-six studies asked respondents about dementia prevention (Fig 1) [21–23,26,27,29–
31,33–35,37–39,41,42,45–50,52–54]. Nearly half of respondents agreed that dementia is a nor-
mal part of ageing (from 13 studies; Median 48%, range 39–74%, n = 12,026) [23,27,28,35,38,
41–43,45,47,51–53] and that dementia is not preventable (from six studies; Median 48%, range
19–59%, n = 9869) [21,38,47,49,53,55]. Consistent with this, one Australian study additionally
reported that only 42 per cent of participants believed they could act to reduce their own risk
(42%, n = 1003) [49]. However, two studies (one in the US and one in the UK) reported high
levels of agreement that genetic factors only partially account for the development of dementia
(Median 83%, range 83–84%, n = 629) [37,50].
Belief that specific non-genetic factors increase the risk for dementia was highest with
alcohol consumption (Median 71%, range 67–88%, n = 1736) [22,26], stroke (Median 62%,
range 33–71%, n = 4137) [22,26–28,35,42,47], stress (Median 56%, range 38–83%, n = 4347)
[22,31,56], and infection (Median 53%, range 14–58%, n = 1736) [22,26]. Fewer than half of
respondents believed that risk for dementia was associated with high cholesterol (Median 47%,
range 25–60%, n = 1014) [29,37,50], hypertension (Median 46%, range 25–60%, n = 1014)
[29,37,50], drug consumption (Median 43%, n = 1476) [22], air pollution (Median 41%, range
26–56%, n = 4013) [34,53], emotional trauma (Median 31%, n = 1476) [22], or psychiatric or
psychological illness (Median 26%, range 21–55%, n = 4063) [22,45]. Despite its well-estab-
lished relationship with dementia, only six per cent of respondents agreed that low education
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increased risk in the one study in which it was included (n = 1111) [45]. Dos Santos et al [22]
reported that 25 per cent of respondents in Portugal believed that ‘use of medications’ could
increase the risk for dementia, but did not specify to which medications this referred
(n = 1476).
Most respondents in six studies did not believe that there are medications available to pre-
vent or reduce the risk of dementia (Median 37%, range 17–53%, n = 6370) [29–31,37,55,56].
On the other hand, 75 per cent of participants in two US studies [31,46] believed vitamins are
available to prevent or reduce risk for dementia (n = 2571). Most respondents in eight studies
agreed that risk for dementia was reduced with mental activity (Median 61%, range 34–95%,
n = 9313) [31,34,37,40,49,50,55,56]. However, when Bowes et al [33] specifically asked why
respondents aged 50–65 years old participated in mental activities, very few reported ranked
dementia risk reduction as their primary aim (1–8%). Belief in physical activity to reduce risk
for dementia was moderate overall (Median = 41%, n = 11,966) but endorsement in individual
studies ranged from 14 to 94 per cent [21,30,31,34,47,49,55,56]. Those with lower endorsement
may be more representative as they tended to employ random digit dialling for recruitment
[30,39] while those with higher endorsement were already involved in a prospective cohort
study of ageing [31] or were recruited from health services [47]. All other non-pharmacologi-
cal prevention strategies were poorly endorsed, including eating a healthy diet (Median 37%,
range 9–89%, n = 10453) [26,30,31,34,49,55,56], not smoking (Median 21%, range 3–39%,
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https://doi.org/10.1371/journal.pone.0196085.t001
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moderate alcohol consumption (Median 5%, n = 1003) [49]. Three per cent of participants in
Luck et al [39] agreed that ‘scientific research’ could reduce the risk for dementia but did not
specify to what research this referred (n = 1002). Finally, Shinan-Altman et al [48] did not
report raw scores and could not be pooled, but reported below average endorsement on a scale
of one (strongly disagree) to five (strongly agree) that AD is attributable to risk factors
(M = 2.47), psychological factors (M = 2.05), and immunity (M = 1.83).
Knowledge about dementia treatment
Twenty-five studies included questions about the efficacy of potential treatments for dementia
(Fig 2) [21–28,32,34–38,40–42,44,45,47,50,52,53,57,58]. The most common question across
studies concerned the availability of a cure, to which 42 per cent agreed (range 6–69%, n =
14,036) [21,26,29,32,34,37,41,44,47,52,53,57,58]. Two studies asked specifically about medica-
tions to cure dementia, but belief that these existed was very low (Median 17%, range 13–24%,
n = 2421) [40,43].
Despite the general consensus that a cure was not available, there was a high level of agree-
ment that people should seek help for memory problems (Median 89%, range 26–95%,
n = 3794) [22,24,32,52]. This was accompanied by a generalised belief that ‘effective treatments
exist’ (Median 55%, range 28–88%, n = 7846) though participants were less convinced that
effective treatments exist to slow the progression of the disease (Median 42%, range 27–84%,
n = 5617) [22,32,34]. There was a strong belief that an effective treatment is available to
Fig 1. Synthesis of public knowledge and beliefs about prevention of dementia.
https://doi.org/10.1371/journal.pone.0196085.g001
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improve the wellbeing of people with dementia in one study with two cohorts (Median = 82%,
range 80–84%, n = 4522) [38].
Two studies reported that participants were mostly aware that pharmacological treatments
are available for dementia (Median 77%, range 63–90%, n = 2587) [22,45], and five studies
reported a general belief that these treatments are effective (Median = 77%, range = 58–84%,
n = 7960) [21,41,44,45]. However, when Picco et al [44] asked about specific medications,
belief in their efficacy ranged from 10% for antibiotics to 50% for antidepressants. Belief in
the efficacy of alternate therapies was moderate overall, including 41% endorsing tonics
and 48% endorsing supplements. No studies asked about the utility of acetylcholinesterase
inhibitors.
Seven studies included questions about the potential for non-pharmacological treatments
to be helpful in the treatment of dementia [21,24,29,37,44,50,52]. Of these, social activity
[44,52] and physical activity [44] were considered most beneficial overall and were both
endorsed by a median of 82% of respondents (social activity range 72–91%, n = 3146; physical
activity n = 3006), followed by relaxation activities (Median 76%, n = 3006) [44], in-person
psychotherapy or counselling (Median 74%, range 70–90%, n = 4330) [44,50,58,59], cutting
out alcohol (Median 62%, n = 3006) [44], and eating a healthy diet (Median 59%, range 34–
78%, n = 4330). Picco et al [44] additionally noted that most respondents endorsed seeking
help from close family (Median 84%) and friends (Median 78%), and yoga or meditation
(Median 68%). Religious or spiritual methods (Median 34%, range 22–45%, n = 3056) [24,44]
and natural therapies (Median 18%, n = 50) [24] were endorsed by fewer than half of
Fig 2. Synthesis of public knowledge and beliefs about treatments for dementia.
https://doi.org/10.1371/journal.pone.0196085.g002
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respondents included. The value of educating the person with dementia about their illness was
recognised in two studies both conducted in Asia (Median 76%, range 65–89%, n = 5670)
[21,44].
Two studies asked respondents about specific health professionals who could be helpful in
the treatment of dementia [24,44]. Both reported a high level of belief that a general practi-
tioner can be helpful (Median 73%, range 73–74%, n = 3056). Picco et al [44] additionally
reported a moderate to high level of endorsement for psychiatrists (Median 83%), psycholo-
gists (Median 74%), and social workers (Median 66%), but not for traditional Chinese medi-
cine practitioners (Median 29%), among the general public in Singapore. Hailstone et al [25]
reported results on a scale from 1 (strongly disagree) to 7 (strongly agree) and so could not be
pooled, but participants overall agreed that they would want to see their doctor if they had
memory problems, that seeking help from their doctor would be beneficial, valuable, and
good, and that their doctor would be able to provide treatments to help with memory
problems.
Trends by time, location
Survey administration year (where reported) was plotted against endorsement of the four
most commonly included statements across studies (Fig 3). A downward trend was noted in
belief that there is a cure for dementia, while belief that effective treatments exist appears to
have increased over time. The understanding that dementia is a preventable disease also
appears to be increasing. However, belief that dementia is a normal part of ageing has
remained relatively steady over the eight-year period.
Pooled responses to these same questions were stratified by continent (Table 2). No striking
patterns emerged, and continents were relatively homogenous in their knowledge. European
and American respondents were more likely than Asians and Australians to believe dementia
Fig 3. Trends by time.
https://doi.org/10.1371/journal.pone.0196085.g003
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is a normal part of ageing. Six studies gathered views of specific ethnic groups within high-
income countries, but results were unremarkable relative to other studies.
Discussion
The aim of this review was to compare the general public’s understanding of dementia as a
preventable and treatable condition to contemporary scientific evidence. Thirty-three eligible
surveys of the general population were identified, conducted predominantly in Europe and the
US and occasionally in Eastern Asia and Australia. Results suggest that knowledge about the
potential for dementia risk reduction and treatment of symptoms remains poor but may be
improving over time. Knowledge and attitudes of those living in low- and middle-income
countries are largely unknown.
Main findings
Twenty-five of the studies included in this review were published since a narrative review of
public knowledge and attitudes about dementia was published in 2014 [11]. Results of that
review were strikingly similar to those reported here, including the common misconception
that dementia is a normal part of ageing and is not preventable. As authors of the earlier review
point out, these misconceptions have been documented for decades even among health profes-
sionals who diagnose and treat dementia [60]. There were some positive signs in terms of
improvements in awareness over time, particularly among ethnic minority groups living in
high-income countries. Cognitive leisure activities in particular appear to be well understood
as good candidates for dementia prevention or delay, consistent with some evidence that they
can delay the onset of dementia [2]. On the other hand, the importance of formal educational
attainment and management of cardiovascular were acknowledged by fewer than half of
respondents who were asked about them.
Despite the generalised understanding that dementia is usually a terminal condition with-
out an available cure belief in the value of seeking treatment was high in almost all studies and
suggests a positive shift in attitudes away from fatalistic beliefs that have acted as a barrier to
help seeking in the past [61]. It was noted, however, that the perceived value in treatment lay
mostly in its potential to support wellbeing rather than slow the progression of symptoms.
This is contrary to evidence that both pharmacological and non-pharmacological methods can
delay functional and cognitive decline [3,62]. The general public was positive overall about the
value of practicing healthy behaviours after a diagnosis of dementia. Whether these strategies
were believed to limit progression of disease or were simply viewed as valuable health
Table 2. Trends by continent.
Pooled median (range)
Europe US Asia Australia
Dementia is a normal part of ageing 53% (28–74) 53% (14–72) 43% (16–66) 39% (n/a)
n = 6837 n = 1483 n = 4667 n = 1049
Dementia is not preventable 53% (45–54) n/a 28% (19–50) 59% (n/a)
n = 5524 n = 5115 n = 1003
There is a cure for dementia 56% (6–69) 38% (16–64) 38% (13–62) n/a
n = 5828 n = 1100 n = 8261
Effective treatments exist for dementia 40% (27–88) 59% (46–81) n/a n/a
n = 10100 n = 1346
n/a = Not available
https://doi.org/10.1371/journal.pone.0196085.t002
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behaviours more generally (as has been demonstrated in the past [63]) was not explored and is
an important avenue for future research
There were large geographic and cultural gaps in the available literature. Low-income coun-
tries were not represented, and populous countries with rapidly ageing populations were nota-
bly missing (e.g. Japan, India). Given the socio-economic homogeneity of countries where
data is available, it is not surprising that no major trends emerged in comparisons by conti-
nent. The lack of data in low- and middle-income countries was also noted by Cahill and col-
leagues in their earlier review [11]. That little progress has been made to fill this gap in the
subsequent years is troubling particularly because most people with dementia live in low- and
middle-income regions [1] and because structural barriers to awareness and help-seeking are
more common in those regions [13]. Gathering a baseline understanding of public knowledge
and attitudes in low- and middle-income regions is essential for development of targeted pub-
lic awareness campaigns.
Strengths and limitations of review and included studies
This review benefited from a robust search strategy that was complemented by a thorough
examination of the grey literature. It is the first to inductively pool similar responses and pres-
ent findings visually for ease of interpretation and analysis of trends over time. Nonetheless,
the results should be interpreted in the context of important limitations. First, studies pub-
lished in languages other English were excluded and this may have precluded the representa-
tion of many regions and cultural groups. This is particularly important given how little is
known about knowledge and attitudes in non-English speaking regions, and the structural bar-
riers to awareness raising that exist in these regions. Second, nearly half of the included studies
did not report their response rate. Of those that did (n = 17), only eight reported a rate above
60 per cent. Non-response bias is possible and the reported views may overestimate general
population knowledge. On the other hand, publication bias and selective reporting within
studies is possible if authors choose to publish findings only where knowledge is ‘remarkably’
low. This is less likely given the variety in knowledge levels reported by the included studies,
but some bias may still exist. Third, synthesising the data via quantitative meta-analysis was
precluded by heterogeneity of the questions posed. Pooling ‘like’ themes was considered more
appropriate in this case. Finally, an analysis of themes from qualitative studies in subsequent
reviews will add depth to our understanding of public awareness, including the socio-political
factors that allow misconceptions to persist.
Implications
Results of this study suggest several key areas of need in general public dementia literacy. The
view that dementia is a normal part of ageing with few treatment options is a demonstrated
barrier to both preventive health behaviours and to help-seeking and diagnosis in the event
that symptoms emerge [12]. Stigmatisation occurs in the absence of accurate understanding,
and contributes to social isolation and emotional distress for people with dementia and their
carers [13].
While the proliferation of public awareness campaigns and dementia-friendly community
initiatives in high-income countries appears to be having a positive impact, gaps in knowledge
remain and present key target areas for future campaigns. First, a significant underestimation
of the importance of non-genetic cognitive and cardiovascular risk factors is evident and is not
helped by confusing messaging about what is and is not harmful [17]. Dementia is a complex
syndrome for which the impact of risk factors can vary depending on the type of dementia,
timing of exposure, confluence of risks, and pre-existing genetic susceptibilities [6]. The
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quality of evidence regarding individual risks varies, and conflicting findings regularly emerge.
In this context, researchers have a responsibility to disseminate their findings to the public in
ways that do not promote misunderstandings, including working in partnership with the
mainstream media. In the meantime, simple messaging about the net benefit of healthy behav-
iours over the life course may be most beneficial.
Second, there appears to be a misconception that available treatments are useful only for
maintaining the wellbeing of people with dementia and are not able to slow progression of dis-
ease. This may be related to the focus in public awareness campaigns on the serious conse-
quences of dementia. While ‘fear appeal’ campaigns can promote investments in research and
care [64], they also (by nature) promote fear of the illness. This messaging must be comple-
mented by evidence-based campaigns emphasising the value of seeking a diagnosis and
treatment.
Third, the public tended to endorse poorly supported risk reduction strategies (like vita-
mins) over more powerful but also more effortful strategies (like exercise). Promotion of realis-
tic risk reduction messages necessitates debunking less relevant strategies to reduce noise.
Finally, the misconception that dementia is a normal part of ageing is persisting despite
decades of public health efforts contrasting this message. New strategies are clearly required to
address this.
Policy-makers in low and middle-income countries, especially those developing their first
dementia action plans, will benefit from a better understanding of the barriers to knowledge in
their countries and cost-effective methods to overcome these. The potential reach of public
awareness campaigns is ever-increasing as technology makes information more accessible. At
the same time, the media landscape is crowded and public health agencies must compete for
attention [65]. The WHO Global Action Plan [9] advocates for both national and local public
health campaigns that are community- and culture-specific and developed in consultation
with people living with dementia and their carers. Educating children and young people may
have particular benefits, as this approach can foster intergenerational solidarity and prepare a
future generation of informal carers [13]. The introduction of alternative terminology (neuro-
cognitive disorders) in the most recent iteration of the Diagnostic and Statistical Manual for
Mental Disorders [66] was intended to reduce the stigma associated with ‘dementia’ (a term
meaning ‘mad’ or ‘insane’ in Latin). Increasing use of this terminology may help to correct
long-held misconceptions about dementia and frame a new understanding of the condition
among the general public. Most importantly, creative messaging and methods of delivery must
be paired with a supportive environment that enables the public to take the action advocated
in the campaign [65]. Without sustainable infrastructure to facilitate risk reduction and help
seeking, the benefits of improving public awareness will be stifled.
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